What You Should Know:
– SHINE Technologies, a nuclear fusion company with an expanding platform of medical isotope products, today announced it has entered into a definitive agreement to acquire the SPECT (Single-Photon Emission Computed…
Continue Reading
What You Should Know:
– Lantheus Holdings, Inc. (NASDAQ: LNTH), a leading radiopharmaceutical company, announced a definitive agreement to acquire Life Molecular Imaging Ltd. for $350M upfront and up to an additional $400M in potential…
Continue Reading
Introduction
Lantheus Holdings, Inc., a renowned radiopharmaceutical-focused company, has made a significant stride in the cancer care sector by acquiring the global rights to Life Molecular Imaging’s RM2. This novel therapeutic and diagnostic pair targets…
Lantheus Holdings, Inc. celebrates FDA approval for DEFINITY as an ultrasound enhancing agent in pediatric patients with suboptimal echocardiograms. Rigorous clinical trials affirm DEFINITY’s efficacy and safety in this population, marking a significant stride…
Continue Reading
